Are you curious about what clinical trials are and the benefits of participating in one? Learn about how clinical trials work below. This new understanding can empower you to open the door to innovative treatment options for cancer.
Clinical trials, also known as interventional studies, derive their name from being conducted for people or “clinical” subjects. They are led by a principal investigator (PI), who is usually a doctor. The goal of clinical trials is to improve patients' length and health-related quality of life through various medical interventions.
Areas covered by clinical trials may include:
Comparing the current FDA-approved standard care medicines against newer, potentially more effective treatments
Therapies that the FDA has approved, but they look at different ways of administering the treatments, such as in combinations or different doses
Test how new treatments work for a particular disease in a controlled and closely monitored environment
Strategies to reduce side effects related to cancer or its treatments
Health-related quality of life patient surveys
Evaluating new medical devices
Possible benefits you may receive by participating in a clinical trial include:
Early access to effective new treatments if they prove successful
Enhanced medical attention from specialized healthcare professionals
Thorough monitoring for any side effects
An opportunity to actively participate in your healthcare decisions
The chance to aid in the advancement of cancer research and help future patients
The care you receive, including its treatments, may be fully financially covered by the study
Possible risks of participating in a clinical trial may include:
A trial can sometimes require more time and medical attention, such as doctor visits, phone calls, more treatments, a hospital stay, or a more complicated treatment regimen
Side effects the doctor did not anticipate from the treatment
New treatments are not always better than current treatments
The new treatment may not work for you, even if it works for other patients
If the study is double-blind, you may not know which treatment you’ll be assigned to take
What you may pay for in a clinical trial can vary. Typically, the trial's sponsors cover the treatment, but associated care costs like blood tests might not be included and could require insurance coverage. Ask the principal investigator of the trial any questions you have regarding finances, such as whether expenses related to travel or meals during the study period are reimbursed.
To prepare against justifying the trial’s costs as medically necessary for your insurance, you might need to compile a packet of supportive materials, such as relevant medical studies, a letter from your doctor, or endorsements from patient advocacy groups. The trial coordinator can assist you in assembling these documents.
A note about NIH studies: Clinical trials conducted by the National Institutes of Health (NIH) are free with no insurance involved. Travel costs may be covered in certain cases.
Some clinical trials, like Phase I studies involving healthy individuals, may offer compensation ranging from $10-$20 an hour. However, Phase I studies involving people with cancer generally do not pay for participation.
How to find paid clinical trials: To learn if the study you would like to participate in compensates volunteers, please read the trial’s informed consent form. You can also contact the study’s principal investigator for financial-related questions.
Each clinical trial has rules called eligibility criteria that dictate who can join the study. These include inclusion and exclusion criteria and are set up to preserve the health-related safety of the participants.
Eligibility criteria may include factors like:
Age
Prior medications taken
Cancer stage
Cancer type
Eastern Cooperative Oncology Group performance status (measures your ability to complete daily tasks)
Health history (vaccination record, prior surgeries, comorbidities, active infections)
Ability to understand and willingness to sign a written informed consent document
These criteria are located on the trial’s page. If you have questions about the study’s criteria, please reach out to the principal investigator whose contact information is also listed on the trial’s page.
Every clinical trial is governed by a detailed protocol, which includes the treatment plan, the types of medical tests participants might undergo, the number of participants involved, eligibility criteria, and safety information. An extensive informed consent process is integral to this, where potential participants are educated about the trial's objectives, duration, procedures, all potential risks and benefits, and the confidentiality of their medical records.
If you decide to join, you'll sign a consent form summarizing this information, which you can reference at any time. Importantly, signing the form does not waive your right to withdraw from the study at any point. Informed consent is an ongoing process, allowing for updates on trial progress, emerging side effects, or other risks as they become known.
Clinical trials are only conducted after preclinical research is finished, a period when the treatment is evaluated not on people. The medicine only moves forward into a clinical trial if there is enough evidence that the therapy has a good chance of helping individuals.
The phases of clinical trials include:
PHASE 0
Phase 0 trials are the first clinical trials that involve people. This phase aims to learn how a medicine is processed in the body, how it affects the body, and whether it reaches cancer cells. A minimal dose of medicine is given to about 10 to 15 people.
PHASE I
This phase is generally tested in a small group of 15 to 30 patients and seeks to find out:
If the new treatment is safe (fewest side effects)
The best way to give the new treatment, such as by mouth or by vein, and at what dose
If there are signs that cancer responds to the new treatment
PHASE II
Phase II trials are conducted in groups of less than 100 patients to further analyze the safety of medicines and determine whether they work.
PHASE III
The purpose of the phase III trial is to compare the new medicine to the current medicine it could replace. This phase monitors each medicine's side effects and determines which works better. It is tested in hundreds to thousands of patients.
Patients who enroll in a Phase III clinical trial have a chance of being in one of the following randomly selected groups:
Control group: Receives the current standard treatment
Study group: Receives the new treatment being tested
You don’t get to choose which group you are in; this is assigned at random. You might also not know which group you’re in until the trial ends.
PHASE IV
Phase IV trials continue testing new medicines that the FDA has recently approved. The medicine is tested in hundreds to thousands of patients worldwide, allowing for a better understanding of its short—and long-term side effects, safety, and benefits.
In general, the amount of time a study takes varies by phase. Other factors like how long it takes to enroll participants and what the study is trying to accomplish can also influence time.
Phase I: The shortest phase, usually takes less than a year to complete
Phase II: Often lasts up to two years
Phase III: Can last up to 5 years
Phase IV: Can last several years
Phases II-IV of a clinical trial can often take several years because time is needed to study the long-term effects of a treatment. Your participation in the trial, however, may be shorter than its full duration because participants can join the study at different times.
As a volunteer, you have the freedom to discontinue your involvement in a clinical trial whenever you choose. It is advisable to consult your doctor before making this decision to discuss potential health implications, the safest method to stop the medications, and alternative treatment options available to you. If you find that the clinical trial is not meeting your needs, you may opt to withdraw and explore other trials or different treatment approaches.
Now that you understand the gist of clinical trials, how do you find one that suits your needs? Strategies may include:
Ask a cancer specialist about clinical trials you are eligible for
Review HealthTree’s clinical trial finder by clicking here
If you are not finding a clinical trial on HealthTree’s site, you can also visit clinicaltrials.gov for a more comprehensive list
Stay tuned to HealthTree news articles, which cover some of the latest updates on blood cancer clinical trials
Participating in a clinical trial that aligns with your needs may help provide you access to some of the best new therapies that are not readily available to the general public. Your participation can also help researchers and doctors gather data that improves the treatment landscape for other people with cancer.
Click the button below to access HealthTree’s clinical trial finder, opening the door to potential innovative treatment options.
Sources:
Are you curious about what clinical trials are and the benefits of participating in one? Learn about how clinical trials work below. This new understanding can empower you to open the door to innovative treatment options for cancer.
Clinical trials, also known as interventional studies, derive their name from being conducted for people or “clinical” subjects. They are led by a principal investigator (PI), who is usually a doctor. The goal of clinical trials is to improve patients' length and health-related quality of life through various medical interventions.
Areas covered by clinical trials may include:
Comparing the current FDA-approved standard care medicines against newer, potentially more effective treatments
Therapies that the FDA has approved, but they look at different ways of administering the treatments, such as in combinations or different doses
Test how new treatments work for a particular disease in a controlled and closely monitored environment
Strategies to reduce side effects related to cancer or its treatments
Health-related quality of life patient surveys
Evaluating new medical devices
Possible benefits you may receive by participating in a clinical trial include:
Early access to effective new treatments if they prove successful
Enhanced medical attention from specialized healthcare professionals
Thorough monitoring for any side effects
An opportunity to actively participate in your healthcare decisions
The chance to aid in the advancement of cancer research and help future patients
The care you receive, including its treatments, may be fully financially covered by the study
Possible risks of participating in a clinical trial may include:
A trial can sometimes require more time and medical attention, such as doctor visits, phone calls, more treatments, a hospital stay, or a more complicated treatment regimen
Side effects the doctor did not anticipate from the treatment
New treatments are not always better than current treatments
The new treatment may not work for you, even if it works for other patients
If the study is double-blind, you may not know which treatment you’ll be assigned to take
What you may pay for in a clinical trial can vary. Typically, the trial's sponsors cover the treatment, but associated care costs like blood tests might not be included and could require insurance coverage. Ask the principal investigator of the trial any questions you have regarding finances, such as whether expenses related to travel or meals during the study period are reimbursed.
To prepare against justifying the trial’s costs as medically necessary for your insurance, you might need to compile a packet of supportive materials, such as relevant medical studies, a letter from your doctor, or endorsements from patient advocacy groups. The trial coordinator can assist you in assembling these documents.
A note about NIH studies: Clinical trials conducted by the National Institutes of Health (NIH) are free with no insurance involved. Travel costs may be covered in certain cases.
Some clinical trials, like Phase I studies involving healthy individuals, may offer compensation ranging from $10-$20 an hour. However, Phase I studies involving people with cancer generally do not pay for participation.
How to find paid clinical trials: To learn if the study you would like to participate in compensates volunteers, please read the trial’s informed consent form. You can also contact the study’s principal investigator for financial-related questions.
Each clinical trial has rules called eligibility criteria that dictate who can join the study. These include inclusion and exclusion criteria and are set up to preserve the health-related safety of the participants.
Eligibility criteria may include factors like:
Age
Prior medications taken
Cancer stage
Cancer type
Eastern Cooperative Oncology Group performance status (measures your ability to complete daily tasks)
Health history (vaccination record, prior surgeries, comorbidities, active infections)
Ability to understand and willingness to sign a written informed consent document
These criteria are located on the trial’s page. If you have questions about the study’s criteria, please reach out to the principal investigator whose contact information is also listed on the trial’s page.
Every clinical trial is governed by a detailed protocol, which includes the treatment plan, the types of medical tests participants might undergo, the number of participants involved, eligibility criteria, and safety information. An extensive informed consent process is integral to this, where potential participants are educated about the trial's objectives, duration, procedures, all potential risks and benefits, and the confidentiality of their medical records.
If you decide to join, you'll sign a consent form summarizing this information, which you can reference at any time. Importantly, signing the form does not waive your right to withdraw from the study at any point. Informed consent is an ongoing process, allowing for updates on trial progress, emerging side effects, or other risks as they become known.
Clinical trials are only conducted after preclinical research is finished, a period when the treatment is evaluated not on people. The medicine only moves forward into a clinical trial if there is enough evidence that the therapy has a good chance of helping individuals.
The phases of clinical trials include:
PHASE 0
Phase 0 trials are the first clinical trials that involve people. This phase aims to learn how a medicine is processed in the body, how it affects the body, and whether it reaches cancer cells. A minimal dose of medicine is given to about 10 to 15 people.
PHASE I
This phase is generally tested in a small group of 15 to 30 patients and seeks to find out:
If the new treatment is safe (fewest side effects)
The best way to give the new treatment, such as by mouth or by vein, and at what dose
If there are signs that cancer responds to the new treatment
PHASE II
Phase II trials are conducted in groups of less than 100 patients to further analyze the safety of medicines and determine whether they work.
PHASE III
The purpose of the phase III trial is to compare the new medicine to the current medicine it could replace. This phase monitors each medicine's side effects and determines which works better. It is tested in hundreds to thousands of patients.
Patients who enroll in a Phase III clinical trial have a chance of being in one of the following randomly selected groups:
Control group: Receives the current standard treatment
Study group: Receives the new treatment being tested
You don’t get to choose which group you are in; this is assigned at random. You might also not know which group you’re in until the trial ends.
PHASE IV
Phase IV trials continue testing new medicines that the FDA has recently approved. The medicine is tested in hundreds to thousands of patients worldwide, allowing for a better understanding of its short—and long-term side effects, safety, and benefits.
In general, the amount of time a study takes varies by phase. Other factors like how long it takes to enroll participants and what the study is trying to accomplish can also influence time.
Phase I: The shortest phase, usually takes less than a year to complete
Phase II: Often lasts up to two years
Phase III: Can last up to 5 years
Phase IV: Can last several years
Phases II-IV of a clinical trial can often take several years because time is needed to study the long-term effects of a treatment. Your participation in the trial, however, may be shorter than its full duration because participants can join the study at different times.
As a volunteer, you have the freedom to discontinue your involvement in a clinical trial whenever you choose. It is advisable to consult your doctor before making this decision to discuss potential health implications, the safest method to stop the medications, and alternative treatment options available to you. If you find that the clinical trial is not meeting your needs, you may opt to withdraw and explore other trials or different treatment approaches.
Now that you understand the gist of clinical trials, how do you find one that suits your needs? Strategies may include:
Ask a cancer specialist about clinical trials you are eligible for
Review HealthTree’s clinical trial finder by clicking here
If you are not finding a clinical trial on HealthTree’s site, you can also visit clinicaltrials.gov for a more comprehensive list
Stay tuned to HealthTree news articles, which cover some of the latest updates on blood cancer clinical trials
Participating in a clinical trial that aligns with your needs may help provide you access to some of the best new therapies that are not readily available to the general public. Your participation can also help researchers and doctors gather data that improves the treatment landscape for other people with cancer.
Click the button below to access HealthTree’s clinical trial finder, opening the door to potential innovative treatment options.
Sources:
about the author
Megan Heaps
Megan joined HealthTree in 2022. As a writer and the daughter of a blood cancer patient, she is dedicated to helping patients and their caregivers understand the various aspects of their disease. This understanding enables them to better advocate for themselves and improve their treatment outcomes. In her spare time, she enjoys spending time with her family, sewing, and cooking.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.